Bourgeon Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,550
| Closed | -$11K | – | 431 |
|
|
2022
Q2 | $11K | Hold |
2,550
| – | – | ﹤0.01% | 218 |
|
|
2022
Q1 | $15K | Buy |
2,550
+1,300
| +104% | +$7.65K | ﹤0.01% | 213 |
|
|
2021
Q4 | $9K | Buy |
+1,250
| New | +$9K | ﹤0.01% | 222 |
|
|
2019
Q2 | – | Sell |
-10,050
| Closed | -$96K | – | 78 |
|
|
2019
Q1 | $96K | Sell |
10,050
-7,350
| -42% | -$70.2K | 0.06% | 69 |
|
|
2018
Q4 | $200K | Buy |
17,400
+5,750
| +49% | +$66.1K | 0.13% | 61 |
|
|
2018
Q3 | $197K | Buy |
+11,650
| New | +$197K | 0.1% | 71 |
|
|
2017
Q3 | – | Sell |
-11,500
| Closed | -$101K | – | 93 |
|
|
2017
Q2 | $101K | Sell |
11,500
-20,700
| -64% | -$182K | 0.06% | 77 |
|
|
2017
Q1 | $167K | Sell |
32,200
-17,000
| -35% | -$88.2K | 0.1% | 78 |
|
|
2016
Q4 | $150K | Buy |
49,200
+3,700
| +8% | +$11.3K | 0.09% | 84 |
|
|
2016
Q3 | $211K | Sell |
45,500
-3,500
| -7% | -$16.2K | 0.14% | 81 |
|
|
2016
Q2 | $284K | Buy |
49,000
+5,500
| +13% | +$31.9K | 0.18% | 70 |
|
|
2016
Q1 | $263K | Buy |
43,500
+26,000
| +149% | +$157K | 0.18% | 72 |
|
|
2015
Q4 | $160K | Buy |
+17,500
| New | +$160K | 0.1% | 87 |
|